These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 16413464

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Requirement for CDK4 kinase function in breast cancer.
    Yu Q, Sicinska E, Geng Y, Ahnström M, Zagozdzon A, Kong Y, Gardner H, Kiyokawa H, Harris LN, Stål O, Sicinski P.
    Cancer Cell; 2006 Jan; 9(1):23-32. PubMed ID: 16413469
    [Abstract] [Full Text] [Related]

  • 4. Cyclin-dependent kinase 4 expression is essential for neu-induced breast tumorigenesis.
    Reddy HK, Mettus RV, Rane SG, Graña X, Litvin J, Reddy EP.
    Cancer Res; 2005 Nov 15; 65(22):10174-8. PubMed ID: 16288002
    [Abstract] [Full Text] [Related]

  • 5. Suppression of Neu-induced mammary tumor growth in cyclin D1 deficient mice is compensated for by cyclin E.
    Bowe DB, Kenney NJ, Adereth Y, Maroulakou IG.
    Oncogene; 2002 Jan 10; 21(2):291-8. PubMed ID: 11803472
    [Abstract] [Full Text] [Related]

  • 6. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P.
    Cancer Res; 2006 May 01; 66(9):4672-80. PubMed ID: 16651418
    [Abstract] [Full Text] [Related]

  • 7. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.
    Corsino P, Davis B, Law M, Chytil A, Forrester E, Nørgaard P, Teoh N, Law B.
    Cancer Res; 2007 Apr 01; 67(7):3135-44. PubMed ID: 17409420
    [Abstract] [Full Text] [Related]

  • 8. Specific protection against breast cancers by cyclin D1 ablation.
    Yu Q, Geng Y, Sicinski P.
    Nature; 2001 Jun 28; 411(6841):1017-21. PubMed ID: 11429595
    [Abstract] [Full Text] [Related]

  • 9. ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo.
    Casimiro M, Rodriguez O, Pootrakul L, Aventian M, Lushina N, Cromelin C, Ferzli G, Johnson K, Fricke S, Diba F, Kallakury B, Ohanyerenwa C, Chen M, Ostrowski M, Hung MC, Rabbani SA, Datar R, Cote R, Pestell R, Albanese C.
    Cancer Res; 2007 May 01; 67(9):4364-72. PubMed ID: 17483350
    [Abstract] [Full Text] [Related]

  • 10. Cyclin d1 overexpression sensitizes breast cancer cells to fenretinide.
    Pirkmaier A, Yuen K, Hendley J, O'Connell MJ, Germain D.
    Clin Cancer Res; 2003 May 01; 9(5):1877-84. PubMed ID: 12738746
    [Abstract] [Full Text] [Related]

  • 11. Synergistic effect of cyclin D1 and c-Myc leads to more aggressive and invasive mammary tumors in severe combined immunodeficient mice.
    Wang Y, Thakur A, Sun Y, Wu J, Biliran H, Bollig A, Liao DJ.
    Cancer Res; 2007 Apr 15; 67(8):3698-707. PubMed ID: 17440082
    [Abstract] [Full Text] [Related]

  • 12. Cyclin D1/cdk4 can interact with E2F4/DP1 and disrupts its DNA-binding capacity.
    Scimè A, Li L, Ciavarra G, Whyte P.
    J Cell Physiol; 2008 Mar 15; 214(3):568-81. PubMed ID: 17894419
    [Abstract] [Full Text] [Related]

  • 13. Isolation and characterization of cytoplasmic cyclin D1 mutants.
    Murakami H, Horihata M, Andojo S, Yoneda-Kato N, Kato JY.
    FEBS Lett; 2009 May 19; 583(10):1575-80. PubMed ID: 19409388
    [Abstract] [Full Text] [Related]

  • 14. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
    van Rossum AG, van Bragt MP, Schuuring-Scholtes E, van der Ploeg JC, van Krieken JH, Kluin PM, Schuuring E.
    BMC Cancer; 2006 Mar 14; 6():58. PubMed ID: 16536875
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma.
    Molenaar JJ, Ebus ME, Koster J, van Sluis P, van Noesel CJ, Versteeg R, Caron HN.
    Cancer Res; 2008 Apr 15; 68(8):2599-609. PubMed ID: 18413728
    [Abstract] [Full Text] [Related]

  • 19. Nuclear factor of activated T cells c1 mediates p21-activated kinase 1 activation in the modulation of chemokine-induced human aortic smooth muscle cell F-actin stress fiber formation, migration, and proliferation and injury-induced vascular wall remodeling.
    Kundumani-Sridharan V, Singh NK, Kumar S, Gadepalli R, Rao GN.
    J Biol Chem; 2013 Jul 26; 288(30):22150-62. PubMed ID: 23737530
    [Abstract] [Full Text] [Related]

  • 20. The role of the cyclin D1-dependent kinases in ErbB2-mediated breast cancer.
    Yang C, Ionescu-Tiba V, Burns K, Gadd M, Zukerberg L, Louis DN, Sgroi D, Schmidt EV.
    Am J Pathol; 2004 Mar 26; 164(3):1031-8. PubMed ID: 14982856
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.